Avricore Health
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Avricore Health generated cash of $660,403, which is more than the previous year. Cash used in financing activities reached the amount of $42,500 last year. Net change in cash is therefore -$343,956.
Cash Flow
| 2015 | -1.92M | -30.84K | 3.36M |
|---|---|---|---|
| 2016 | -2.06M | -6.34K | 362K |
| 2017 | -1.76M | -132.55K | 2.03M |
| 2018 | -1.72M | -155K | 1.40M |
| 2019 | -686.40K | 0 | 615.76K |
| 2020 | -1.22M | 0 | 1.51M |
| 2021 | -1.23M | -140.36K | 3.08M |
| 2022 | -437.83K | -1.20M | 253.88K |
| 2023 | 660.40K | -1.04M | 42.5K |
AVCR.V Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 620.52K | 2.01M | 302.71K | 13.79K | 84.44K | 559.73K | 427.48K | 2.13M | 295.37K |
Operating activities | |||||||||
Net income | -701.21K | -818.22K | -1.70M | -1.17M | -1.91M | -4.13M | -2.73M | -2.61M | -2.81M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 420.06K | 183.04K | 17.98K | 0 | 180.46K | 535.50K | 13.85K | 14.66K | 20.46K |
Stock-based compensation expense | 703.61K | 331.52K | 495.79K | 130.21K | 86.42K | 372.13K | 311.38K | 922.92K | 1.27M |
| Deferred income tax benefit | 703.61K | 331.52K | 495.79K | 130.21K | 86.42K | 372.13K | 311.38K | 922.92K | 1.27M |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | 338.09K | -687.49K | -79.62K | 3.54K | 0 | 170.15K | 268.96K | -606.20K | -93.43K |
Inventories | -20.67K | -268.41K | 69.59K | -180.43K | 0 | -118.29K | 99.08K | -207.22K | -1.14M |
Accounts payable | 176.32K | 268.41K | -69.59K | -339.04K | 364.30K | -53.64K | -58.04K | 111.11K | 0 |
Cash generated by operating activities | 660.40K | -437.83K | -1.23M | -1.22M | -686.40K | -1.72M | -1.76M | -2.06M | -1.92M |
Investing activities | |||||||||
Purchases Of Investments | 0 | -10K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -1.02M | -1.19M | -140.36K | 0 | 0 | -55K | -3.78K | -6.34K | -30.84K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | -100K | -128.76K | 0 | 0 |
Cash generated by investing activities | -1.04M | -1.20M | -140.36K | 0 | 0 | -155K | -132.55K | -6.34K | -30.84K |
Financing activities | |||||||||
Common Stock Issued | 42.5K | 253.88K | 2.40M | 626K | 637.07K | 780.83K | 1.57M | 362K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -1M | -13.69K | -52.00K | 0 | 0 | 0 | -32.97K |
Cash used in financing activities | 42.5K | 253.88K | 3.08M | 1.51M | 615.76K | 1.40M | 2.03M | 362K | 3.36M |
Net Change In Cash | -343.95K | -1.39M | 1.71M | 288.91K | -70.64K | -475.29K | 132.25K | -1.70M | 2.42M |
Cash at end of period | 276.57K | 620.52K | 2.01M | 302.71K | 13.79K | 84.44K | 559.73K | 427.48K | 2.72M |